Vitamin D Pilot Study in Patients With Multiple Sclerosis
Vitamin D Pilot Study in Patients With Multiple Sclerosis
What it found
We found no results in the registry or in papers.
This trial finished 26 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Cholecalciferol
Vitamin D receptor agonist
What it measured
Main measures
MRI Measure of new active lesions, observation vs. treatment
MRI lesions
Who could take part
Relapsing MS · 18 to 45
Show the full criteria
Inclusion criteria
* relapsing remitting MS
Exclusion criteria
* MRI contraindicated
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.
Papers
Loading reviews and guidelines…
Related trials
- Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis
Not a drug-phase study · Completed
No results found
- Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy
Not a drug-phase study · Status unknown
No results found
- Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis
Phase 4 · Status unknown
No results found
- Efficacy of Diet on Quality of Life in Multiple Sclerosis
Not a drug-phase study · Running, not recruiting
Still running
- Prebiotic vs Probiotic in Multiple Sclerosis
Not a drug-phase study · Completed
Paper found, not read
- Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance
Not a drug-phase study · Status unknown
No results found
History
Started
Feb 1998
Main results due
Feb 2000
Finished
Jun 2000